Evolution of novel, orally efficacious renin inhibitors: A topographical design approach towards Aliskiren.

被引:0
|
作者
Maibaum, J [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
50-MEDI
引用
收藏
页码:U9 / U9
页数:1
相关论文
共 50 条
  • [1] Structure-based design of aliskiren, a novel orally effective renin inhibitor
    Wood, JM
    Maibaum, J
    Rahuel, J
    Grütter, MG
    Cohen, NC
    Rasetti, V
    Rüger, H
    Göschke, R
    Stutz, S
    Fuhrer, W
    Schilling, W
    Rigollier, P
    Yamaguchi, Y
    Cumin, F
    Baum, HP
    Schnell, CR
    Herold, P
    Mah, R
    Jensen, C
    O'Brien, E
    Stanton, A
    Bedigian, MP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (04) : 698 - 705
  • [2] Orally efficacious renin inhibitors: New perspectives in a challenging field.
    Maibaum, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U935 - U935
  • [3] Discovery of novel orally bioavailable renin inhibitors by structure based drug design
    Edmunds, Jeremy J.
    Belliotti, Thomas
    Bryant, John
    Cai, Cuiman
    Cheng, Xue Min
    Ciske, Fred L.
    Cody, Wayne L.
    Collard, Wendy
    Downing, Dennis M.
    Erasga, Noe
    Ferreira, Suzie
    Hall, Eric
    Holsworth, Daniel D.
    Jalaie, Mehran
    Kasani, Aparna
    Kaufman, Michael
    Lee, Chitase
    Li, Tingsheng
    Maiti, Samarendra
    McConnell, Patrick
    Mennen, Ken
    Ostroski, Robert
    Powell, Noel A.
    Quinn, John, III
    Rahim, Mohammad
    Ryan, Michael
    Stier, Michael A.
    Subedi, Rajandra
    Van Huis, Chad
    Zhang, Erli
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [4] Design and synthesis of novel potent, non-peptide and orally active renin inhibitors
    Maibaum, J
    Rasetti, V
    Rueger, H
    Cohen, NC
    Goschke, R
    Mah, R
    Rahuel, J
    Grutter, M
    Cumin, F
    Wood, JM
    MEDICINAL CHEMISTRY: TODAY AND TOMORROW, 1997, : 155 - 162
  • [5] Suppression of the renin system by the novel orally effective direct renin inhibitor aliskiren: A pooled analysis of 1612 patients with hypertension
    Gradman, Alan H.
    Flack, John M.
    Arora, Vipin
    Zhang, Jack
    Anderson, David R.
    Keefe, Deborah L.
    Satlin, Andrew
    Prescott, Margaret F.
    CIRCULATION, 2006, 114 (18) : 773 - 773
  • [6] DESIGN AND SYNTHESIS OF NOVEL POTENT, NON-PEPTIDE AND ORALLY ACTIVE RENIN INHIBITORS.
    Grutter, M.
    Maibaum, J.
    Rasetti, V.
    Rueger, H.
    Goschke, R.
    Mah, R.
    Cohen, N. C.
    Rahuel, J.
    Cumin, F.
    Wood, J.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C583 - C583
  • [7] Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
    Tice, Colin M.
    Xu, Zhenrong
    Yuan, Jing
    Simpson, Robert D.
    Cacatian, Salvacion T.
    Flaherty, Patrick T.
    Zhao, Wei
    Guo, Joan
    Ishchenko, Alexey V.
    Singh, Suresh B.
    Wu, Zhongren
    Scott, Boyd B.
    Bukhtiyarov, Yuri
    Berbaum, Jennifer
    Mason, Jennifer
    Panemangalore, Reshma
    Cappiello, Maria Grazia
    Harrison, Richard K.
    McGeehan, Gerard
    Dillard, Lawrence W.
    Baldwin, John J.
    Claremon, David A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [8] Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
    Tice, Colin M.
    Xu, Zhenrong
    Yuan, Jing
    Simpson, Robert D.
    Cacatian, Salvacion T.
    Flaherty, Patrick T.
    Zhao, Wei
    Guo, Joan
    Ishchenko, Alexey
    Singh, Suresh B.
    Wu, Zhongren
    Scott, Boyd B.
    Bukhtiyarov, Yuri
    Berbaum, Jennifer
    Mason, Jennifer
    Panemangalore, Reshma
    Cappiello, Maria Grazia
    Mueller, Dominik
    Harrison, Richard K.
    McGeehan, Gerard M.
    Dillard, Lawrence W.
    Baldwin, John J.
    Claremon, David A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3541 - 3545
  • [9] Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors
    McKittrick, Brian A.
    Caldwell, John P.
    Bara, Thomas
    Boykow, George
    Chintala, Madhu
    Clader, John
    Czarniecki, Michael
    Courneya, Brandy
    Duffy, Ruth
    Fleming, Linda
    Giessert, Rachel
    Greenlee, William J.
    Heap, Charles
    Hong, Liwu
    Huang, Ying
    Iserloh, Ulrich
    Josien, Hubert
    Khan, Tanweer
    Korfmacher, Walter
    Liang, Xian
    Mazzola, Robert
    Mitra, Soumya
    Moore, Kristina
    Orth, Peter
    Rajagopalan, Murali
    Roy, Sudipta
    Sakwa, Samuel
    Strickland, Corey
    Vaccaro, Henry
    Voigt, Johannes
    Wang, Hongwu
    Wong, Jesse
    Zhang, Rumin
    Zych, Andrew
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) : 1592 - 1596
  • [10] Discovery of novel, conformationally restricted, and orally efficacious DGAT1 inhibitors
    Li, Kexue
    Fox, Brian
    Zhang, Jian
    Iio, Kiyosei
    Suzuki, Masahiro
    Soichiro, Ito
    Ozeki, Hidekazu
    Kobayashi, Akio
    Ma, Ji
    Hao, Alan
    Labelle, Marc
    McMinn, Dustin
    Smith, Marie
    Sagawa, Shoichi
    Furukawa, Noboru
    Inaba, Takashi
    Matsushita, Mutsuyoshi
    Matsui, Takuya
    Ogawa, Nobuya
    Okuma, Chihiro
    Sugimoto, Kazuyuki
    Tanaka, Masahiro
    Yoshida, Atsuhito
    Ishii, Yukihito
    Tomimoto, Daisuke
    Jackson, Simon
    Choi, Rebekah
    Shan, Bei
    Srivastava, Ajit
    Kayser, Frank
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245